Telomir Pharmaceuticals Inc (TELO)
6.53
-0.38
(-5.50%)
USD |
NASDAQ |
May 13, 14:13
Telomir Pharmaceuticals Total Assets (Quarterly): 4.774M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.774M |
| September 30, 2023 | 5.319M |
| Date | Value |
|---|---|
| June 30, 2023 | 5.922M |
| December 31, 2022 | 0.0487M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.0487M
Minimum
Dec 2022
5.922M
Maximum
Jun 2023
4.016M
Average
5.046M
Median
Total Assets (Quarterly) Benchmarks
| Kyverna Therapeutics Inc | 75.20M |
| Metagenomi Inc | 364.84M |
| West Pharmaceutical Services Inc | 3.602B |
| Bio-Path Holdings Inc | 3.22M |
| Chromocell Therapeutics Corp | 0.0228M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.336M |
| Shareholders Equity (Quarterly) | 3.438M |